腫瘍切除の世界市場の規模と予測:技術別(高周波、マイクロ波、凍結融解)、治療別(外科的、腹腔鏡的、経皮的)、用途別(肝臓がん、乳がん、肺がん、前立腺がん)、セグメント予測、2015-2022...市場調査レポートについてご紹介

【英文タイトル】Tumor Ablation Market Size & Forecast By Technology (Radiofrequency, Microwave, Cryoablation), By Treatment (Surgical, Laparoscopic, Percutaneous) By Application (Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Cancer), And Trend Analysis From 2015 To 2022

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Content

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Tumor Ablation Devices Market– Industry Snapshot and Key Buying Criteria, 2014
Chapter 3. Tumor Ablation Devices Industry Outlook
3.1. Tumor Ablation Devices Market Segmentation
3.2. Tumor Ablation Devices Market Size and Growth Prospects
3.3. Tumor Ablation Devices Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Industry Analysis – Porter’s
3.5. Tumor Ablation Devices Market PESTEL Analysis, 2014
3.6. Competitive Landscape
Chapter 4. Tumor Ablation Devices Technology Outlook
4.1. Tumor Ablation Devices Market Share By Technology, 2014 & 2022
4.2. Radiofrequency Ablation Devices
4.2.1. Radiofrequency Ablation Devices Market Estimates and Forecasts, 2015 – 2022
4.3. Microwave Ablation Devices
4.3.1. Tumor Ablation Devices Market Estimates and Forecasts, 2015 – 2022
4.4. Cryoablation Devices
4.4.1. Cryoablation Devices Market Estimates and Forecasts, 2015 – 2022
4.5. Other Ablation Devices
4.5.1. Other Ablation Devices Market Estimates and Forecasts, 2015 – 2022
Chapter 5. Tumor Ablation Devices Treatment Outlook
5.1. Tumor Ablation Devices Market Share By Treatment, 2014 & 2022
5.2. Surgical Ablation
5.2.1. Surgical Ablation Market Estimates and Forecasts, 2015 – 2022
5.3. Laparoscopic Ablation
5.3.1. Laparoscopic Ablation Market Estimates and Forecasts, 2015 – 2022
5.4. Percutaneous Ablation
5.4.1. Percutaneous Ablation Market Estimates and Forecasts, 2015 – 2022
Chapter 6. Tumor Ablation Devices Application Outlook
6.1. Tumor Ablation Devices Market Share By Application, 2014 & 2022
6.2. Liver Cancer
6.2.1. Liver Cancer Ablation Devices Market Estimates and Forecasts, 2015 – 2022
6.3. Breast Cancer
6.3.1. Breast Cancer Ablation Devices Market Estimates and Forecasts, 2015 – 2022
6.4. Lung Cancer
6.4.1. Lung Cancer Ablation Devices Market Estimates and Forecasts, 2015 – 2022
6.5. Prostrate Metastasis
6.5.1. Prostrate Metastasis Ablation Devices Market Estimates and Forecasts, 2015 – 2022
6.6. Other Cancer
6.6.1. Other Cancer Ablation Devices Market Estimates and Forecasts, 2015 – 2022
Chapter 7. Tumor Ablation Devices Regional Outlook
7.1. Tumor Ablation Devices Market Share By Region, 2014 & 2022
7.2. North America
7.2.1. North America Market Estimates and Forecasts, by Technology, 2015 – 2022 (USD Million)
7.2.1.1. U.S. Market Estimates and Forecasts
7.2.1.2. Canada Market Estimates and Forecasts
7.2.2. North America Market Estimates and Forecasts, by Treatment, 2015 – 2022 (USD Million)
7.2.2.1. U.S. Market Estimates and Forecasts
7.2.2.2. Canada Market Estimates and Forecasts
7.2.3. North America Market Estimates and Forecasts, by Application, 2015 – 2022 (USD Million)
7.2.3.1. U.S. Market Estimates and Forecasts
7.2.3.2. Canada Market Estimates and Forecasts
7.3. Europe
7.3.1. Europe Market Estimates and Forecasts, by Technology, 2015 – 2022 (USD Million)
7.3.1.1. Germany Market Estimates and Forecasts
7.3.1.2. UK Market Estimates and Forecasts
7.3.2. Europe Market Estimates and Forecasts, by Treatment, 2015 – 2022 (USD Million)
7.3.2.1. Germany Market Estimates and Forecasts
7.3.2.2. UK Market Estimates and Forecasts
7.3.3. Europe Market Estimates and Forecasts, by Application, 2015 – 2022 (USD Million)
7.3.3.1. Germany Market Estimates and Forecasts
7.3.3.2. UK Market Estimates and Forecasts
7.4. Asia Pacific
7.4.1. Asia Pacific Market Estimates and Forecasts, by Technology, 2015 – 2022 (USD Million)
7.4.1.1. Japan Market Estimates and Forecasts
7.4.1.2. China Market Estimates and Forecasts
7.4.2. Asia Pacific Market Estimates and Forecasts, by Treatment, 2015 – 2022 (USD Million)
7.4.2.1. Japan Market Estimates and Forecasts
7.4.2.2. China Market Estimates and Forecasts
7.4.3. Asia Pacific Market Estimates and Forecasts, by Application, 2015 – 2022 (USD Million)
7.4.3.1. Japan Market Estimates and Forecasts
7.4.3.2. China Market Estimates and Forecasts
7.5. Latin America
7.5.1. Latin America Market Estimates and Forecasts, by Technology, 2015 – 2022 (USD Million)
7.5.1.1. Mexico Estimates and Forecasts
7.5.1.2. Brazil Estimates and Forecasts
7.5.2. Latin America Market Estimates and Forecasts, by Treatment, 2015 – 2022 (USD Million)
7.5.2.1. Mexico Estimates and Forecasts
7.5.2.2. Brazil Estimates and Forecasts
7.5.3. Latin America Market Estimates and Forecasts, by Application, 2015 – 2022 (USD Million)
7.5.3.1. Mexico Estimates and Forecasts
7.5.3.2. Brazil Estimates and Forecasts
7.6. MEA
7.6.1. MEA Market Estimates and Forecasts, by Technology, 2015 – 2022 (USD Million)
7.6.1.1. South Africa Estimates and Forecasts
7.6.1.2. Saudi Arabia Estimates and Forecasts
7.6.2. MEA Market Estimates and Forecasts, by Treatment, 2015 – 2022 (USD Million)
7.6.2.1. South Africa Estimates and Forecasts
7.6.2.2. Saudi Arabia Estimates and Forecasts
7.6.3. MEA Market Estimates and Forecasts, by Application, 2015 – 2022 (USD Million)
7.6.3.1. South Africa Estimates and Forecasts
7.6.3.2. Saudi Arabia Estimates and Forecasts
Chapter 8. Competitive Landscape
8.1. Medtronic Plc.
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. Angiodynamics
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Mermaid Medical
8.3.1. Company Overview
8.3.2. Financial Performance
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. HealthTronics
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Galil Medical Inc.
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. EDAP TMS S.A.
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. Boston Scientific Corporation
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. SonaCare Medical
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. Misonix, Inc.
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. Neuwave Medical, Inc.
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives


【レポート販売概要】

■ タイトル:腫瘍切除の世界市場の規模と予測:技術別(高周波、マイクロ波、凍結融解)、治療別(外科的、腹腔鏡的、経皮的)、用途別(肝臓がん、乳がん、肺がん、前立腺がん)、セグメント予測、2015-2022
■ 英文:Tumor Ablation Market Size & Forecast By Technology (Radiofrequency, Microwave, Cryoablation), By Treatment (Surgical, Laparoscopic, Percutaneous) By Application (Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Cancer), And Trend Analysis From 2015 To 2022
■ 発行日:2016年2月28日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707861
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。